EPIX Pharmaceuticals to Present at the Eighth Annual Structure-Based Drug Design...

EPIX Pharmaceuticals to Present at the Eighth Annual Structure-Based Drug Design Conference

LEXINGTON, Mass.--(Business Wire)--
EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX), a biopharmaceutical
company focused on discovering and developing novel therapeutics
through the use of its proprietary and highly efficient in silico drug
discovery platform, today announced that Sharon Shacham, Ph.D., vice
president of drug development at EPIX, is scheduled to present at the
Eighth Annual Structure-Based Drug Design Conference at the World
Trade Center in Boston on Friday, June 27, 2008 at 11:00 a.m. (ET).
Dr. Shacham's presentation will take place during a session that
focuses on Structure-Based Modeling of GPCRs and the presentation will
feature EPIX's unique approach to drug discovery including their
proprietary PREDICT(TM) technology.

The conference is sponsored by Cambridge Healthtech Institute and
is intended to provide cutting-edge advances in various areas of
research of drug design and discovery. The conference will bring
together an international delegation of chemists, computational
chemists, applications scientists, medicinal chemists and research
technologists.

About EPIX

EPIX Pharmaceuticals is a biopharmaceutical company focused on
discovering and developing novel therapeutics through the use of its
proprietary and highly efficient in silico drug discovery platform.
The company has a pipeline of internally-discovered drug candidates
currently in clinical development to treat diseases of the central
nervous system and lung conditions. EPIX also has collaborations with
leading organizations, including GlaxoSmithKline, Amgen, Cystic
Fibrosis Foundation Therapeutics and Bayer Schering Pharma. For more
information, please visit the company's website at www.epixpharma.com.

This news release contains express or implied forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995 that are based on current expectations of
management. These statements relate to, among other things, our
expectations regarding the timing and content of corporate
presentations. These statements are neither promises nor guarantees,
but are subject to a variety of risks and uncertainties, many of which
are beyond our control, and which could cause actual results to differ
materially from those contemplated in these forward-looking
statements. Existing and prospective investors are cautioned not to
place undue reliance on these forward-looking statements, which speak
only as of the date hereof. We undertake no obligation to update or
revise the information contained in this press release, whether as a
result of new information, future events or circumstances or
otherwise. For additional information regarding these and other risks
that we face, see the disclosure contained in our filings with the
Securities and Exchange Commission, including our most recent Annual
Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q.

EPIX
Kim C. Drapkin, 781-761-7602
Chief Financial Officer
or
Pure Communications
Kelly Hennessy, 617-227-0552

Copyright Business Wire 2008